IN2014DN09774A - - Google Patents

Info

Publication number
IN2014DN09774A
IN2014DN09774A IN9774DEN2014A IN2014DN09774A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A IN 9774DEN2014 A IN9774DEN2014 A IN 9774DEN2014A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A
Authority
IN
India
Prior art keywords
synthesis
activated
improved
disclosed embodiments
intermediates
Prior art date
Application number
Other languages
English (en)
Inventor
Kelly Kraft
John Freeman
Paul Serwinski
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Original Assignee
Mannkind Corp
Kelly Kraft
John Freeman
Serwin Ski Paul
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp, Kelly Kraft, John Freeman, Serwin Ski Paul, Vinnie Pavia, Otto Phantsiel, Navneet Kaur filed Critical Mannkind Corp
Publication of IN2014DN09774A publication Critical patent/IN2014DN09774A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9774DEN2014 2012-04-27 2013-03-15 IN2014DN09774A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (1)

Publication Number Publication Date
IN2014DN09774A true IN2014DN09774A (en:Method) 2015-07-31

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9774DEN2014 IN2014DN09774A (en:Method) 2012-04-27 2013-03-15

Country Status (16)

Country Link
US (6) US9193691B2 (en:Method)
EP (1) EP2841422B1 (en:Method)
JP (1) JP6241682B2 (en:Method)
KR (1) KR20150023315A (en:Method)
CN (2) CN107879938A (en:Method)
AU (2) AU2013252901B2 (en:Method)
BR (1) BR112014026809A2 (en:Method)
CA (1) CA2871126C (en:Method)
HK (1) HK1207382A1 (en:Method)
IL (1) IL235247A0 (en:Method)
IN (1) IN2014DN09774A (en:Method)
MX (1) MX361470B (en:Method)
RU (1) RU2014143116A (en:Method)
SG (1) SG11201406970QA (en:Method)
WO (1) WO2013162764A1 (en:Method)
ZA (1) ZA201408429B (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
PL2322180T3 (pl) 2004-08-23 2015-10-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
CN104324366B (zh) 2005-09-14 2016-10-05 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
KR20080096809A (ko) 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR20180079458A (ko) 2009-06-12 2018-07-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
BR112012033060A2 (pt) 2010-06-21 2018-02-27 Mannkind Corp métodos de sistema de liberação de fármaco em pó seco
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
BR112014026809A2 (pt) * 2012-04-27 2017-06-27 Mannkind Corp métodos para a síntese de etilfumaratos ativados e seu uso como intermediários
SG10201605800UA (en) 2012-07-12 2016-09-29 Mannkind Corp Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN117646042B (zh) * 2023-11-13 2025-04-11 浙江工业大学 一种富马酸单酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
PL2322180T3 (pl) 2004-08-23 2015-10-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
KR20080096809A (ko) * 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
JP5788806B2 (ja) * 2008-12-29 2015-10-07 マンカインド コーポレイション 薬物送達剤用置換ジケトピペラジン及びその塩、これらを含む治療用組成物、微粒子組成物及び乾燥粉末組成物、並びに、その調整方法
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2427430B1 (en) * 2009-05-04 2014-09-10 The Royal Institution for the Advancement of Learning/McGill University 5-oxo-ete receptor antagonist compounds
CN101851213A (zh) * 2010-06-21 2010-10-06 于清 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法
CN103534242B (zh) 2011-02-10 2016-04-20 曼坎德公司 N-保护的双-3,6-(4-氨基烷基)-2,5-二酮哌嗪的形成
BR112014026809A2 (pt) * 2012-04-27 2017-06-27 Mannkind Corp métodos para a síntese de etilfumaratos ativados e seu uso como intermediários

Also Published As

Publication number Publication date
EP2841422B1 (en) 2019-08-28
US10858325B2 (en) 2020-12-08
US20190010131A1 (en) 2019-01-10
US20210114994A1 (en) 2021-04-22
AU2018201397A1 (en) 2018-03-22
US9193691B2 (en) 2015-11-24
EP2841422A4 (en) 2016-04-13
BR112014026809A2 (pt) 2017-06-27
AU2013252901A1 (en) 2014-11-06
EP2841422A1 (en) 2015-03-04
CA2871126C (en) 2020-07-14
AU2013252901B2 (en) 2017-11-30
SG11201406970QA (en) 2014-11-27
MX2014013075A (es) 2015-08-14
WO2013162764A1 (en) 2013-10-31
ZA201408429B (en) 2021-05-26
US20230057608A1 (en) 2023-02-23
CA2871126A1 (en) 2013-10-31
US10071969B2 (en) 2018-09-11
US20250109109A1 (en) 2025-04-03
AU2018201397B2 (en) 2019-05-02
US20130289278A1 (en) 2013-10-31
RU2014143116A (ru) 2016-06-20
US11479535B2 (en) 2022-10-25
CN104797563B (zh) 2017-12-15
HK1207382A1 (en) 2016-01-29
CN104797563A (zh) 2015-07-22
US20160159753A1 (en) 2016-06-09
CN107879938A (zh) 2018-04-06
IL235247A0 (en) 2014-12-31
JP2015519321A (ja) 2015-07-09
JP6241682B2 (ja) 2017-12-06
MX361470B (es) 2018-12-06
US12202807B2 (en) 2025-01-21
KR20150023315A (ko) 2015-03-05

Similar Documents

Publication Publication Date Title
IN2014DN09774A (en:Method)
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
EP2526199A4 (en) PROCESS FOR PRODUCING ZINC FINGERUCLEASES WITH CHANGED EFFECT
WO2012050975A3 (en) Novel circular mammalian rna molecules and uses thereof
MY168935A (en) Synthesis of heterocyclic compounds
MX2013004870A (es) Procedimiento para producir aerogeles o xerogeles.
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
EP2556042A4 (en) INTEGRATED METHOD FOR THE SIMULTANEOUS PREPARATION OF TRANS-1-CHLORO-3,3,3-TRIFLUORPROPES AND TRANS-1,3,3,3-TETRAFLUORPROPES
TNSN08513A1 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
WO2012006440A3 (en) Endothelial cell production by programming
HUE037914T2 (hu) Reaktor és eljárás foszgén elõállításához
UA94639C2 (ru) Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
EP2080749A4 (en) PROCESS FOR SYNTHESIS OF A CHEMICAL-INDUSTRIAL RAW MATERIAL OR A FUEL COMPOSITION
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
EP2691396A4 (en) ENOPEPTINES, USES THEREOF AND SYNTHESIS METHOD THEREFOR
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
WO2011129636A3 (ko) 초급속연소법을 이용한 나노전극재료 합성방법 및 그 방법으로 합성된 나노전극재료
PH12015500712A1 (en) Azaquinazoline carboxamide derivatives
GB201103256D0 (en) Solid support and method of recovering biological material therefrom